Pabst, T., Vey, N., Adès, L., Bacher, U., Bargetzi, M., Fung, S., Gaidano, G., Gandini, D., Hultberg, A., Johnson, A., Ma, X., Müller, R., Nottage, K., Papayannidis, C., Recher, C., Riether, C., Shah, P., Tryon, J., Xiu, L. and Ochsenbein, A. F. (2023) “Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy”, Haematologica. Pavia, Italy, 108(7), pp. 1793-1802. doi: 10.3324/haematol.2022.281563.